- Home
- Gastroenterology
- Dupilumab in Eosinophilic Gastritis: A New Era in Targeted Therapy

4w3 min read
Medical Article
Introduction: Eosinophilic gastrointestinal disorders (EGIDs) are a group of chronic, immune-mediated inflammatory diseases characterized by eosinophil-predominant infiltration of the gastrointestinal (GI) tract in the absence of identifiable secondary causes of eosinophilia, such as drug reactions, parasitic infections, or malignancy (1). This spe

Dupilumab in Eosinophilic Gastritis: A New Era in Targeted Therapy
224 Reached
Similar Content

Study evaluating Effectiveness of Bacillus clausii for Treatment of Rotavirus Infection
1303 Reached4 Comments6 Likes

SECCA for Managing Anal Incontinence
203 Reached2 Comments2 Likes

Single-incision Laparoscopy for Gastrostomy
407 Reached2 Comments1 Likes

Abnormal Biliary Imaging in Patient with history of Hypothyroidism
116 Reached1 Comments2 Likes

Psychological Manifestations Of IBS
662 Reached1 Comments1 Likes